Today, neurodegenerative diseases are affecting more and individuals. A typical therapeutic target to treat the progression of symptoms related these is proinflammatory microglia. Diapocynin, dimeric version apocynin, often drug choice. However, suitable carriers for its controlled delivery currently lacking in clinics. In fact, high hydrophilicity hampers development a formulation enabling sus...